Thrombolytic treatment
Development of a decision analytic model to support decision making and risk communication about thrombolytic treatment
... (net) treatment effect of thrombolysis (absolute dif- ference in probability of independence [mRS ≤ 2] in treated and untreated ...with treatment effect we assumed that the treatment effect reported ...
11
Thrombolytic treatment (alteplase; rt-PA) in acute massive pulmonary embolism and cardiopulmonary arrest
... Currently, thrombolytic therapy for PE is still ...received thrombolytic treatment were retrospectively ...rt-PA treatment were hemorrhage in five ...This thrombolytic treatment ...
5
A review of decision support, risk communication and patient information tools for thrombolytic treatment in acute stroke: lessons for tool developers
... of treatment with and without the available options (and absolute difference in terms of likely benefit or harm) using natural frequencies [61,74,75] with identical denom- inators and time horizons that relate to ...
13
Evaluation of pre-hospital transport time of stroke patients to thrombolytic treatment
... Poulakka et al. [11] and Quain et al. [12] assessed the duration from onset of symptoms, instead of the time of initial contact with emergency services, and in the two studies found symptom-to-door times of 71 and 63.5 ...
5
31P Spectroscopy in Thrombolytic Treatment of Experimental Cerebral Infarct
... While a large embolus within the cervical portion of the internal carotid artery of a human patient often gives rise to severe infarcts of the cerebral hemispheres, a similarly located e[r] ...
6
Acute thrombosis of the intracranial dural sinus: direct thrombolytic treatment
... We are reporting our experience with successful direct urokinase thrombolytic therapy in three cases of superior sagittal sinus and two cases of transverse and sigmoid sinus thrombosis..[r] ...
5
Susceptibility Weighted Imaging: Technical Aspects and Clinical Applications, Part 2
... Old microbleeds in patients with stroke have been studied in terms of their relationship to the potential for hemorrhagic transformation in the thrombolytic treatment of patients with ac[r] ...
21
Cardiac Arrest Caused by Multiple Recurrent Pulmonary Embolism
... anticoagulant treatment in the prevention of pulmonary embolism ...(3) Thrombolytic treatment should always be considered and may be life-saving in patients with cardiac arrest suspected to be caused ...
5
Quality of life of elderly ischaemic stroke patients one year after thrombolytic therapy. A comparison between patients with and without thrombolytic therapy
... In total, two hundred and thirty-five patients were diag- nosed with ischemic stroke, of which eighty-two patients received thrombolytic treatment. Ultimately, eighty-eight interviews were conducted, with ...
9
PHYTOCHEMICAL INVESTIGATION, CYTOTOXIC AND THROMBOLYTIC ACTIVITY OF ACETONE EXTRACTS OF RHYNCHOTECHUM ELLIPTICUM (GESNERIACEAE)
... of thrombolytic drugs, that are either that, is obtained from Streptococcus species or using recombinant biotechnology whereby tPA is actually manufactured by bacteria, resulting in a recombinant tissue ...
9
Efficacy and safety of thrombolytic therapy in prosthetic valve thrombosis
... of thrombolytic treatment in PVT ...study. Thrombolytic therapy was administered as an intravenous infusion of streptokinase or urokinase, initially at a loading dose of ...
5
Factors Influencing the outcome of Thrombolysis in Acute Myocardial Infarction among Non Smokers
... Results of FTT group which performed a comprehensive overview of nine trials of thrombolytic treatment each of which enrolled more than 1000 patients showed that there was an 18% decreas[r] ...
82
Quantification of Thrombus Hounsfield Units on Noncontrast CT Predicts Stroke Subtype and Early Recanalization after Intravenous Recombinant Tissue Plasminogen Activator
... Little is known about the factors that determine the success of intravenous thrombolysis in patients with acute stroke. Age, stroke severity, systolic hypertension, hyperglycemia, HMCAS, and time to thrombolytic ...
7
BRINE SHRIMP LETHALITY BIOASSAY, THROMBOLYTIC AND ANTIBACTERIAL ACTIVITIES OF METHANOL EXTRACT OF BOEHMERIA PLATYPHYLLA D DON LEAVES
... Boehmeria platyphylla D Don is a monoecious or dioecious, 1-1.5 (-3) m tall, shrub with 4-angled, glabrescent twigs. Leaves mostly opposite, with 2.5- 20 cm long petiole; lamina 3-costate, broadly ovate to orbiculate, ...
8
EVALUATION OF THROMBOLYTIC EFFICACY OF HERBS: JUSTICIA ADHATODA AND ACACIA NILOTICA BY IN-VITRO CLOT LYSIS TECHNIQUE
... Results of the study give a scientific support for the traditional claims for the plants J.adhatoda and A.nilotica as thrombolytic agents. According to this study a significant and linear relationship exist ...
13
PHYTOCHEMICAL SCREENING AND PHARMACOLOGICAL STUDIES OF METHANOL EXTRACT OF POLYALTHIA SUBEROSA ROXB.
... micro-centrifuge tube containing pre-weighed clot, 100 μl solution of different extracts, concentration 1 mg/mL, were added accordingly. As a positive control, 100 μl of streptokinase and asn a negative non ...
13
Thrombolytic Therapy in the Acute Period of Aortic Thromboembolism in Cats
... Of the best available evidence, four of the studies were retrospective case series. Three of these studies were included to provide survival information for those that did not receive thrombolytic therapy and the ...
14
INVESTIGATION OF IN VITRO THROMBOLYTIC AND IN VIVO ANTIPYRETIC, ANTIDEPRESSANT POTENTIALITY AND ANALGESIC ACTIVITY WITH PHYTO CHEMICAL NATURE OF METHANOLIC EXTRACT OF NYMPHOIDES HYDROPHYLLA
... Hole Cross Test (HCT): This method was described by Takagi et al., 1971 25 . A partition was fixed in the middle of a cage having a size of 30 × 20 × 14 cm. A hole of 3 cm diameter was made at the height of 7.5 cm in the ...
9
THROMBOLYTIC EFFECT OF THREE NSAIDS: IN VITRO AND IN SILICO APPROACH
... the thrombolytic effect of some NSAIDs by in vitro clot lysis method and in silico molecular docking used to identify whether these drugs interact with the responsible protein (tissue-type plasminogen ...the ...
9
In Vitro Antioxidant and Thrombolytic Activity of Artocarpus chaplasha Leaves
... and treatment of diseases human races are dependent on medicinal plant and today most of the Food and Drug Administration (FDA) approved pharmaceuticals are of plant origin ...
7